Your session is about to expire
← Back to Search
Behavioural Intervention
Intervention for Alzheimer's Disease (ABCV Trial)
N/A
Recruiting
Led By Alexia M Torke, MD, MS
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients aged 65 and older
Diagnosis of Alzheimer's disease and related dementias (ADRD) based on ICD criteria in primary care problems list
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during the 12 months of intervention
Awards & highlights
ABCV Trial Summary
This trial involves a virtual intervention program where registered nurses or social workers will provide support to care partners over a year. The care partners will have monthly virtual visits for the first 3 months and then less
Who is the study for?
This trial is for individuals with dementia or Alzheimer's Disease. Participants will engage in a virtual care program over one year, managed by nurses or social workers. The program includes regular check-ins and personalized plans to manage symptoms and caregiver stress.Check my eligibility
What is being tested?
The Aging Brain Care Virtual Program is being tested to see if it can help manage dementia and Alzheimer's symptoms through monthly virtual visits initially, then quarterly as needed. It focuses on behavioral management, stress relief for caregivers, medication oversight, comorbidity handling, and future care planning.See study design
What are the potential side effects?
Since this intervention is non-medical and involves virtual support sessions rather than drugs or medical procedures, there are no traditional side effects; however participants may experience varying levels of emotional response to the support provided.
ABCV Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 65 years old or older.
Select...
I have been diagnosed with Alzheimer's or a similar dementia.
ABCV Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ during the 12 months of intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during the 12 months of intervention
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Emergency Department Utilization
Secondary outcome measures
New prescriptions for antipsychotic medications
New prescriptions for benzodiazepine medications
Other outcome measures
Anticholinergic Cognitive Burden Scale score
ABCV Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Care Partners in the intervention group will be approached and offered care coordination through the Aging Brain Care Virtual program
Group II: ControlActive Control1 Intervention
Care partners in the control group will not be approached, but outcomes data will be collected from the EMR for comparison with the intervention group.
Find a Location
Who is running the clinical trial?
Regenstrief Institute, Inc.OTHER
26 Previous Clinical Trials
97,617 Total Patients Enrolled
Indiana University HealthOTHER
30 Previous Clinical Trials
15,173 Total Patients Enrolled
Indiana UniversityLead Sponsor
980 Previous Clinical Trials
980,902 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there currently opportunities for individuals to enroll in this research study?
"As per details on clinicaltrials.gov, the current investigation is not actively seeking volunteers. Initially shared on 2/15/2024 and last revised on 1/30/2024, this particular trial does not have vacancies for participants presently. Nonetheless, it's worth noting that there are a total of 768 other ongoing studies currently open for recruitment."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger